Latest Penn studies of personalized cell therapies define optimal doses

(University of Pennsylvania School of Medicine) More precise dosing methods and cellular engineering techniques show promise in the effort to improve treatment of aggressive cancers with personalized cellular therapies, according to new studies from researchers in the Perelman School of Medicine and the Abramson Cancer Center at the University of Pennsylvania and The Children's Hospital of Philadelphia which will be presented during the 2016 American Society of Clinical Oncology Annual Meeting.